HUMIRA

Generic: ADALIMUMAB

Manufacturer: Abbvie Inc.

Folate Analog Metabolic Inhibitor [EPC]Tumor Necrosis Factor Blocker [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Vitamin C [EPC]
695,826
Total Reports
196,301
Serious Reports
28,959
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.16%)

Patient Demographics

Male
209,786
Female
446,643

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for HUMIRA.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 90,713
11.5%
2 PAIN 49,061
6.2%
3 ARTHRALGIA 48,039
6.1%
4 INJECTION SITE PAIN 47,251
6.0%
5 FATIGUE 39,112
5.0%
6 RHEUMATOID ARTHRITIS 35,573
4.5%
7 HEADACHE 28,330
3.6%
8 NAUSEA 27,103
3.4%
9 DIARRHOEA 25,415
3.2%
10 RASH 25,271
3.2%
11 PSORIASIS 24,707
3.1%
12 PAIN IN EXTREMITY 24,313
3.1%
13 JOINT SWELLING 23,283
2.9%
14 INCORRECT DOSE ADMINISTERED 22,332
2.8%
15 MALAISE 21,339
2.7%
16 OFF LABEL USE 20,957
2.7%
17 NASOPHARYNGITIS 20,605
2.6%
18 CROHN^S DISEASE 19,602
2.5%
19 PYREXIA 18,994
2.4%
20 DEVICE ISSUE 17,971
2.3%
21 DRUG INTOLERANCE 17,172
2.2%
22 ALOPECIA 16,685
2.1%
23 VOMITING 16,428
2.1%
24 CONDITION AGGRAVATED 16,337
2.1%
25 INJECTION SITE HAEMORRHAGE 16,123
2.0%
26 ABDOMINAL PAIN 15,667
2.0%
27 PNEUMONIA 15,566
2.0%
28 DYSPNOEA 15,480
2.0%
29 PERIPHERAL SWELLING 15,188
1.9%
30 INJECTION SITE ERYTHEMA 15,181
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.